Kyverna Therapeutics 与 Elevatebio 正式签署了一项针对 Miv-Cel 的商业化生产及供应协议。这一合作标志着双方在细胞治疗领域的战略布局迈出了关键一步，旨在确保 Miv-Cel 能够顺利进入规模化生产阶段，并满足未来市场的潜在需求。通过整合 Elevatebio 的制造专长与 Kyverna 的研发能力，该协议有望加速这一创新疗法的商业化进程。
Kyverna Therapeutics 与 Elevatebio 正式签署了一项针对 Miv-Cel 的商业化生产及供应协议。这一合作标志着双方在细胞治疗领域的战略布局迈出了关键一步，旨在确保 Miv-Cel 能够顺利进入规模化生产阶段，并满足未来市场的潜在需求。通过整合 Elevatebio 的制造专长与 Kyverna 的研发能力，该协议有望加速这一创新疗法的商业化进程。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.